Gene Expression of Protein Tyrosine Phosphatase 1B and Endoplasmic Reticulum Stress During Septic Shock

Protein Tyrosine Phosphatase 1B (PTP1B) and endoplasmic reticulum stress (ERS) are involved in the septic inflammatory response. Their inhibition is associated with improved survival in murine models of sepsis. In a recent publication in Frontiers in Medicine Dr Clavier et al showed in a study of 40 patients with septic shock that gene expression variation in blood samples of PTPN1 and ATF6  partly correlate with the evolution of septic organ failure and with markers of endothelial dysfunction. The recent identification of PTP1B as a novel negative regulator of host defense against sepsis may have potential therapeutic implications. However, further studies are needed to better understand PTP1B and ERS implication during sepsis in humans.

 

Thesis defense 2019

logo presThis autumn four PhD students have defended their thesis in our laboratory:

- Mouad Hamzaoui
- Bérénice Colleville
- Frédéric Roca
- Matthieu Leuillier

 

 

20191126 Mouad

Dr Mouad Hamzaoui (Dir. Dominique Guerrot)

"Rôle de la dysfonction endothéliale dans les complications cardiovasculaires et rénales de la polykystose rénale autosomique dominante: intérêt d’une modulation pharmacologique par agonistes dopaminergiques"

20191209 Berenice

Dr Bérénice Colleville (Dir. Eric Durand)

"Identification de nouvelles cibles thérapeutiques dans le rétrécissement aortique"

 20191212 Fred Roca

Dr Frédéric Roca (Dir Robinson Joannides)

"Évaluation in vivo de la viscosité pariétale des artères de conductance : impact du vieillissement, de la dysfonction endothéliale et de la réduction pharmacologique de la fréquence cardiaque"

20191216 Matthieu

Dr Matthieu Leuillier (Dir. Jeremy Bellien)

"Rôle de l'activité phosphatase de l'époxyde hydrolase soluble dans la régulation de l'homéostasie métabolique et cardiovasculaire"

PhD positions available in our group old

Two PhD positions are available in our Unit, starting september 2019. Please contact us for further details:

This email address is being protected from spambots. You need JavaScript enabled to view it.   This email address is being protected from spambots. You need JavaScript enabled to view it.

Arterial viscosity increase in essential hypertension

ArFigure thumbnail fx1terial wall viscosity is regulated by endothelium-derived NO and epoxyeicosatrienoic acids (EETs) under baseline physiological conditions. Whether these factors regulate arterial viscosity during blood flow increase and whether this mechanism is affected in patients with essential hypertensive have remained unknown.

In a recent publication in Atherosclerosis Dr Roca et al showed in a study of 18 untreated hypertensive patients and 14 normotensive controls that baseline arterial viscosity was increased in hypertensive patients. Whereas pharmacological inhibition of NO and/or EETs increased arterial viscosity in response to flow-mediated dilatation, these inhibitors did not modify the arterial viscosity in hypertensive patients.

Thus, the release of NO and EETs maintains a stable arterial wall viscosity during flow increase and this endothelial adaptive regulation is lost during essential hypertension, which may promote excessive viscous energy dissipation and cardiovascular uncoupling. Restoration of EETs availability with inhibitors of soluble epoxide hydrolase could thus constitute a promising pharmacological approach to restore the endothelial adaptive regulation of AWV.

PhD positions available in our group

Two PhD positions are available in our Unit, starting september 2019.

Impact de l’inhibition de la protéine PTP1B dans des modèles expérimentaux d’hypertension artérielle

Encadrant : Pr V Richard

Co-encadrant: Dr J Wils

Interaction Moléculaire Entre Lymphocytes et Lymphatiques cardiaques (IMEL²)

Encadrant : Dr E Brakenhielm

 

Une allocation doctorale d’une durée de 3 ans est disponible dans l’Unité INSERM U1096 Endothelium, Valvulopathy & Heart Failure (Pr. Vincent Richard, UFR Santé Rouen). Cette allocation doctorale est destinée à un projet de thèse qui portera sur les effets de l’inhibition ou de l’ invalidation génique de la protéine Protein Tyrosine Phosphatase 1B (PTP1B) dans un modèle animal d’hypertension artérielle.

Le candidat, en cours de M2R ou titulaire d’un M2R, aura une appétence pour l’expérimentation animale et la physiologie cardiovasculaire.

 Cette allocation doctorale est destinée à un projet vise à caractériser les interactions moléculaires entre des cellules immunitaires et les vaisseaux lymphatiques lors de l’inflammation cardiaque afin de développer des nouveaux outils permettant de résoudre l’inflammation lors des maladies cardiovasculaires et limiter le développement de l’insuffisance cardiaque. 

Le candidat, en cours de M2R ou titulaire d’un M2R, aura une appétence pour la physiologie cardiovasculaire ainsi que l'immunologie.

Please contact us for further details:
This email address is being protected from spambots. You need JavaScript enabled to view it.     This email address is being protected from spambots. You need JavaScript enabled to view it.

                       

INSERM U1096

Endothelium, Valvulopathy
& Heart Failure

Réalisation Internet Bordeaux LOGO internet bordeaux mini

Contact Us

Legal mentions